David M O'Malley

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurr...

Clinical cancer research : an official journal of the American Association for Cancer Research · 17 februari 2026

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of EN...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-09

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3,...

European journal of cancer (Oxford, England : 1990) · 25 juli 2025

Relacorilant and nab-paclitaxel in patiënten met platinum-resistant ovarian cancer (ROSELLA): an open-label, randomis...

Lancet (London, England) · 21 juni 2025

Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patiënte...

The Lancet. Oncology · 2025-04

Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 piv...

European journal of cancer (Oxford, England : 1990) · 26 maart 2025

Long-Term Follow-Up and Totale overleving in NRG258, a Gerandomiseerde Fase III Trial of Chemoradiation Versus Chemot...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 maart 2025

Moleculaire resultaten en biomarkers van MILO/ENGOT-ov11 binimetinib bij LGSC

Clinical cancer research : an official journal of the American Association for Cancer Research · 13 oktober 2023

Rucaparib-onderhoud bij ovariumcarcinoom ongeacht BRCA-status: ATHENA-MONO fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 december 2022

Trametinib versus standaard bij recidief laaggradige sereuze ovariumcarcinoom: GOG 281/LOGS fase II/III

Lancet (London, England) · 5 februari 2022

Binimetinib versus chemotherapie bij recidief laaggradige sereuze ovariumcarcinoom: MILO/ENGOT-ov11

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 november 2020

Carboplatine-paclitaxel met of zonder trastuzumab bij laaggradig sereus of endometrioïd ovariumcarcinoom: NRG/GOG-0213 subanalyse

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 augustus 2020

Predictieve bloedgebaseerde biomarkers bij ovariumcarcinoom onder carboplatine-paclitaxel-bevacizumab

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 maart 2020

Adjuvante chemotherapie plus bestraling bij lokaal gevorderd endometriumcarcinoom: GOG 258 fase III

The New England journal of medicine · 13 juni 2019

Trebananib plus carboplatine-paclitaxel als eerstelijns bij ovariumcarcinoom: TRINOVA-3 fase III

The Lancet. Oncology · 2019-06

Rucaparib-onderhoud bij recidief ovariumcarcinoom na platinarespons: ARIEL3 fase III-studie

Lancet (London, England) · 28 oktober 2017

Bevacizumab plus paclitaxel-carboplatine en secundaire cytoreductie bij platinagevoelig recidief ovariumcarcinoom: MITO16B-MaNGO OV2B-ENGOT OV17

The Lancet. Oncology · 2017-06

Wekelijks versus driewekelijks paclitaxel-carboplatine bij ovariumcarcinoom

The New England journal of medicine · 25 februari 2016